Summary of Study ST003347

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002082. The data can be accessed directly via it's Project DOI: 10.21228/M8H24R This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST003347
Study TitleADSL deficiency drives mitochondrial dysfunction and ERK2 dysregulation in a linear genotype to phenotype correlation
Study SummaryAdenylosuccinate lyase (ADSL) deficiency (ADSLd) is a rare autosomal recessive defect of purine metabolism associated with a wide range of clinical manifestations. Despite ADSL implication in purine synthesis, no additional molecular alterations have been identified as a cause of ADSLd besides the accumulation of toxic substrates. Here we uncover a novel association between ADSLd and mitochondrial dysfunction, which is characterized by an increase in fragmentation and reduction in respiration and ATP production. The extent of this mitochondrial dysfunction is directly proportional to the pathological manifestations of ADSLd, which are predominantly observed in tissues that rely heavily on mitochondria. Our analysis also unveils a striking defect in mitochondrial dynamics and transport, which are associated with the suppression of ERK2 and AKT function. Remarkably, the mitochondrial phenotype can be rescued in part by overexpression of a constitutive form of ERK2 or through the administration of purine intermediates. This scenario provides an alternative explanation of ADSLd onset, reorienting research towards developing innovative therapeutic strategies based on the restoration of mitochondrial metabolism.
Institute
Catholic University of the Sacred Heart
Last NameBordi
First NameMatteo
AddressLargo Francesco Vito 1, Rome, Italy, 00168, Italy
Emailmatteo.bordi@unicatt.it
Phone+390630155135/5258
Submit Date2024-07-12
Raw Data AvailableYes
Raw Data File Type(s)raw(Thermo)
Analysis Type DetailLC-MS
Release Date2024-08-15
Release Version1
Matteo Bordi Matteo Bordi
https://dx.doi.org/10.21228/M8H24R
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR002082
Project DOI:doi: 10.21228/M8H24R
Project Title:ADSL deficiency drives mitochondrial dysfunction and ERK2 dysregulation in a linear genotype to phenotype correlation
Project Summary:Adenylosuccinate lyase (ADSL) deficiency (ADSLd) is a rare autosomal recessive defect of purine metabolism associated with a wide range of clinical manifestations. Despite ADSL implication in purine synthesis, no additional molecular alterations have been identified as a cause of ADSLd besides the accumulation of toxic substrates. Here we uncover a novel association between ADSLd and mitochondrial dysfunction, which is characterized by an increase in fragmentation and reduction in respiration and ATP production. The extent of this mitochondrial dysfunction is directly proportional to the pathological manifestations of ADSLd, which are predominantly observed in tissues that rely heavily on mitochondria. Our analysis also unveils a striking defect in mitochondrial dynamics and transport, which are associated with the suppression of ERK2 and AKT function. Remarkably, the mitochondrial phenotype can be rescued in part by overexpression of a constitutive form of ERK2 or through the administration of purine intermediates. This scenario provides an alternative explanation of ADSLd onset, reorienting research towards developing innovative therapeutic strategies based on the restoration of mitochondrial metabolism.
Institute:Catholic University of the Sacred Heart
Last Name:Bordi
First Name:Matteo
Address:Largo Francesco Vito 1, Rome, Italy, 00168, Italy
Email:matteo.bordi@unicatt.it
Phone:+390630155135/5258

Subject:

Subject ID:SU003468
Subject Type:Cultured cells
Subject Species:Homo sapiens
Taxonomy ID:9606
Species Group:Mammals

Factors:

Subject type: Cultured cells; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id Genotype Sex
SA365169BT02-040A3V/R337X F
SA365170BT02-039A3V/R337X F
SA365171BT02-038A3V/R337X F
SA365172BT02-037A3V/R337X F
SA365173BT02-036A3V/R337X F
SA365174BT02-021M26L/R396H F
SA365175BT02-025M26L/R396H F
SA365176BT02-023M26L/R396H F
SA365177BT02-022M26L/R396H F
SA365178BT02-024M26L/R396H F
SA365179BT02-029M26L/R396H M
SA365180BT02-027M26L/R396H M
SA365181BT02-030M26L/R396H M
SA365182BT02-028M26L/R396H M
SA365183BT02-026M26L/R396H M
SA365184BT02-035R309H/c.1191+5G->C F
SA365185BT02-031R309H/c.1191+5G->C F
SA365186BT02-032R309H/c.1191+5G->C F
SA365187BT02-033R309H/c.1191+5G->C F
SA365188BT02-034R309H/c.1191+5G->C F
SA365189BT02-010Wildtype F
SA365190BT02-009Wildtype F
SA365191BT02-006Wildtype F
SA365192BT02-008Wildtype F
SA365193BT02-007Wildtype F
SA365194BT02-005Wildtype M
SA365195BT02-004Wildtype M
SA365196BT02-003Wildtype M
SA365197BT02-012Wildtype M
SA365198BT02-013Wildtype M
SA365199BT02-002Wildtype M
SA365200BT02-011Wildtype M
SA365201BT02-015Wildtype M
SA365202BT02-014Wildtype M
SA365203BT02-001Wildtype M
Showing results 1 to 35 of 35

Collection:

Collection ID:CO003461
Collection Summary:2x105 cells were plated onto 60mm plates in DMEM media (5 replicates for each cell type). After two days, before extraction, cells were counted using CASY cell counter (Omni Life Sciences) using a separate counting plate. After that, cells were washed at room temperature with PBS twice and then kept in a cold bath with dry ice and methanol before adding the metabolite extraction solution.
Sample Type:Skin

Treatment:

Treatment ID:TR003477
Treatment Summary:Cells were cultured in DMEM media supplemented with 10% FBS

Sample Preparation:

Sampleprep ID:SP003475
Sampleprep Summary:Metabolite extraction solution (50% methanol, 30% acetonitrile, 20% ultrapure water, 5 µM final concentration valine-d8) was added to each well after the washes in PBS following the proportion of 1ml of extraction solution per million cells. The extracts were scraped and mixed at 4°C for 15 min. After final centrifugation at max speed for 15 min at 4°C, the supernatants were transferred into LC-MS vials.

Chromatography:

Chromatography ID:CH004165
Instrument Name:Dionex Ultimate 3000 UHPLC
Column Name:SeQuant ZIC- pHILIC (150 x 2.1mm,5um)
Column Temperature:40
Flow Gradient:0-2 min: 80% B; 2-17 min: linear gradient from 80% B to 20% B; 17-17.1 min: linear gradient from 20% B to 80% B; 17.1-23 min: hold at 80% B.
Flow Rate:0.200 mL/min
Solvent A:100% water; 20 mM ammonium carbonate; 0.05% ammonium hydroxide
Solvent B:100% acetonitrile
Chromatography Type:HILIC

Analysis:

Analysis ID:AN005482
Analysis Type:MS
Chromatography ID:CH004165
Num Factors:6
Num Metabolites:147
Units:peak area
  logo